CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency

NCT07015801 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Viremia
Cytomegalovirus Pneumonia
T-Lymphocyte Immunodeficiency

Interventions

BIOLOGICAL: CMV-VST

Sponsor

University of Calgary

Collaborators

[object Object]
[object Object]
[object Object]